The first patient has been recruited to the LIBERATE trial studying the GPVI blocking Fab glenzocimab in acute coronary syndromes. The trial is led by Mark Thomas.
Bham Platelet Group
@bhamplateletgrp
The Birmingham Platelet Group adopts a multidisciplinary approach in the investigation of platelet and megakaryocyte biology.
115 Following 695 Followers 413 Posts
Latest posts 5
Congratulations to Pushpa Patel on the award of her PhD on platelet activation by nanoparticles supervised by Paula Mendes (Chem Eng) and Steve Watson
We are very pleased to be recognised for the manuscript 'Martin et al in the first issue of @JTHjournal 2024 on multivalent nanobodies as novel ligands for four platelet glycoprotein receptors
Congratulations to @bhamplateletgrp who have been recognised in the Pharmaceutical Technology Excellence Awards 2023 for their work on nanobodies. 👏The researchers have been announced as winners in the category of Innovation. @ICVS_UoB @unibirmingham birmingham.ac.uk/news/2024/birm…View quoted post on X
Many congrats to @sam_310 who won the poster prize at the annual @BritSocHaemThro meeting, to Rich Buka & Alex Slater who gave invited talks in the emerging fellows programme, Gill Lowe who gave a fantastic plenary and @GinaPerrella who opened the abstracts with a great talk.
Well done to @TAPAS_ITN and @ICVS_UoB student, Dr Xueqing Wang (centre) who passed her PhD viva on 3rd March! The title of her thesis was "Characterisation of platelet membrane receptors in their native environment using SMALP nanodiscs".